Breast Cancer Stem Cells Express HER2, Even In 'Negative' Tumors, Study Finds
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread...
More... |
Re: Breast Cancer Stem Cells Express HER2, Even In 'Negative' Tumors, Study Finds
Well . . . duh! Dr. George Peoples already figured that out.
So if you know of anyone diagnosed as a lower expressor, please have them consider this clinical trial: http://www.clinicaltrials.gov/ct2/sh...2E75%22&rank=1 There are other trials, just for vaccines in progress for lower expressors of Her2 http://www.cancernetwork.com/display.../10165/1161656 |
All times are GMT -7. The time now is 12:33 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021